by Portfolio Grader | November 26, 2012 12:02 pm
This week, five Medical Devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Derma Sciences (NASDAQ:DSCI) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Derma Sciences markets and sells a range of skin care, wound management, and specialty securement devices. In Portfolio Grader’s specific subcategories of Earnings Revisions and Sales Growth, DSCI also gets A’s. For more information, get Portfolio Grader’s complete analysis of DSCI stock.
GenMark Diagnostics (NASDAQ:GNMK) gets a higher grade this week, advancing from a B last week to a A. GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. For more information, get Portfolio Grader’s complete analysis of GNMK stock.
Rochester Medical (NASDAQ:ROCM) is seeing ratings go up from a B last week to a A this week. Rochester Medical develops, manufactures and markets latex free disposable urinary continence care products. For more information, get Portfolio Grader’s complete analysis of ROCM stock.
The rating of West Pharmaceutical Services (NYSE:WST) moves up this week, rising from a B to a A. West Pharmaceutical is a manufacturer of components and systems for injectable drug delivery, and plastic packaging and delivery system components for the healthcare and consumer products industries. For more information, get Portfolio Grader’s complete analysis of WST stock.
Exactech (NASDAQ:EXAC) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Exactech develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. For more information, get Portfolio Grader’s complete analysis of EXAC stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
Source URL: http://investorplace.com/2012/11/5-medical-devices-stocks-to-buy-now-dsci-gnmk-rocm/
Short URL: http://investorplace.com/?p=265232
Copyright ©2013 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.